/HNGE
HNGE Stock - Hinge Health, Inc.
Healthcare|Medical - Healthcare Information ServicesNYSE
$47.25-1.66%
$0.80 (-1.66%) • Dec 19
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.44
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+40.7%upside
Target: $66.48
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for HNGE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$46.78 – $47.72
TARGET (TP)$66.50
STOP LOSS$43.47
RISK/REWARD1:5.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta4.72
52W High$62.18
52W Low$33.42
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | $390.40M | $292.73M |
| Gross Profit | $300.59M | $194.18M |
| Gross Margin | 77.0% | 66.3% |
| Operating Income | $-24,429,000 | $-130,514,000 |
| Net Income | $-11,933,000 | $-108,141,000 |
| Net Margin | -3.1% | -36.9% |
| EPS | $-0.15 | $-1.39 |
Company Overview
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
10
91%
Hold / Neutral
1
9%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
10 Bullish1 Neutral/Bearish
Price Targets
$48
Average Target
↑ 0.7% Upside
Now
$41
Low
$48
Average
$58
High
Based on 14 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 5th 2025 | Robert W. Baird | Initiation | Neutral | $56 |
| July 14th 2025 | Citizens JMP | Initiation | Mkt Outperform | $58 |
| June 16th 2025 | William Blair | Initiation | Outperform | - |
| June 16th 2025 | Truist | Initiation | Buy | $48 |
| June 16th 2025 | Stifel | Initiation | Buy | $48 |
| June 16th 2025 | RBC Capital Mkts | Initiation | Outperform | $45 |
| June 16th 2025 | Raymond James | Initiation | Outperform | $45 |
| June 16th 2025 | Piper Sandler | Initiation | Overweight | $41 |
| June 16th 2025 | Morgan Stanley | Initiation | Overweight | $46 |
| June 16th 2025 | Needham | Initiation | Buy | $47 |
| June 16th 2025 | KeyBanc Capital Markets | Initiation | Overweight | $45 |
| June 16th 2025 | Evercore ISI | Initiation | Outperform | $50 |
| June 16th 2025 | Canaccord Genuity | Initiation | Buy | $52 |
| June 16th 2025 | BofA Securities | Initiation | Buy | $42 |
| June 16th 2025 | Barclays | Initiation | Overweight | $43 |
Earnings History & Surprises
HNGEBeat Rate
100%
Last 2 quarters
Avg Surprise
+343.1%
EPS vs Estimate
Beats / Misses
2/0
Last 12 quarters
Latest EPS
$0.34
Q4 2025
EPS Surprise History
Q2 25
No data
Q3 25
+644.4%
$0.67vs$0.09
Q4 25
+41.7%
$0.34vs$0.24
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 3, 2026 | $0.42 | — | — | — |
Q4 2025 | Nov 4, 2025 | $0.24 | $0.34 | +41.7% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $0.09 | $0.67 | +644.4% | ✓ BEAT |
Q2 2025 | May 5, 2025 | — | $0.21 | — | — |
Latest News
Hinge Health Announces $250M Buyback Program
📈 PositiveBenzinga•Nov 12, 2025, 02:01 PM
Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $65
📈 PositiveBenzinga•Nov 5, 2025, 06:18 PM•Also:
Barclays Maintains Overweight on Hinge Health, Raises Price Target to $65
📈 PositiveBenzinga•Nov 5, 2025, 05:28 PM•Also:
Piper Sandler Reiterates Overweight on Hinge Health, Raises Price Target to $71
📈 PositiveBenzinga•Nov 5, 2025, 03:45 PM
Hinge Health shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Nov 5, 2025, 02:01 PM
Hinge Health shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Nov 4, 2025, 09:46 PM
Hinge Health Raises FY2025 Sales Guidance from $548.000M-$552.000M to $572.000M-$574.000M vs $550.507M Est
📈 PositiveBenzinga•Nov 4, 2025, 09:08 PM
Hinge Health Sees Q4 Sales $155.000M-$157.000M vs $145.468M Est
📈 PositiveBenzinga•Nov 4, 2025, 09:07 PM
Hinge Health Q3 EPS $(0.02) Beats $(0.15) Estimate, Sales $154.211M Beat $142.138M Estimate
📈 PositiveBenzinga•Nov 4, 2025, 09:07 PM
Evercore ISI Group Maintains Outperform on Hinge Health, Raises Price Target to $65
📈 PositiveBenzinga•Oct 8, 2025, 01:19 PM
Shares of medical technology stocks are trading lower after the US opened national security investigations into imports of medical equipment, industrial machinery and robotics.
📉 NegativeBenzinga•Sep 25, 2025, 03:11 PM•Also: , ,
Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $67
📈 PositiveBenzinga•Sep 23, 2025, 03:39 PM
Hinge Health shares are trading higher after Stifel maintained a Buy rating on the stock and raised its price target from $63 to $66.
📈 PositiveBenzinga•Sep 11, 2025, 03:18 PM•Also:
Stifel Maintains Buy on Hinge Health, Raises Price Target to $66
📈 PositiveBenzinga•Sep 11, 2025, 01:55 PM•Also:
Baird Initiates Coverage On Hinge Health with Neutral Rating, Announces Price Target of $56
➖ NeutralBenzinga•Sep 5, 2025, 11:09 AM
Digital health company Hinge rises on trading debut
📈 PositiveSeeking Alpha•May 22, 2025, 06:05 PM
Frequently Asked Questions about HNGE
What is HNGE's current stock price?
Hinge Health, Inc. (HNGE) is currently trading at $47.25 per share. The stock has moved -1.66% today.
What is the analyst price target for HNGE?
The average analyst price target for HNGE is $66.50, based on 1 analyst.
What sector is Hinge Health, Inc. in?
Hinge Health, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NYSE exchange.
What is HNGE's market cap?
Hinge Health, Inc. has a market capitalization of $3.72 billion, making it a mid-cap company.
Does HNGE pay dividends?
No, Hinge Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAKRO
Akero Therapeutics, Inc.
$54.65
Mkt Cap: $4.5B
CRNX
Crinetics Pharmaceuticals, Inc.
$48.01
Mkt Cap: $4.6B
DYN
Dyne Therapeutics, Inc.
$19.85
Mkt Cap: $2.8B
IMVT
Immunovant, Inc.
$26.68
Mkt Cap: $4.7B
INDV
Indivior PLC
$35.21
Mkt Cap: $4.4B
LNTH
Lantheus Holdings, Inc.
$65.92
Mkt Cap: $4.5B
OSCR
Oscar Health, Inc.
$14.90
Mkt Cap: $3.8B
PRAX
Praxis Precision Medicines, Inc.
$272.92
Mkt Cap: $5.8B
VKTX
Viking Therapeutics, Inc.
$35.19
Mkt Cap: $4.0B
WGS
GeneDx Holdings Corp.
$140.44
Mkt Cap: $4.1B
Explore stocks similar to HNGE for comparison